All stock lists
Unlock the score
Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
Healthcare · Biotechnology
15.73+0.11 (+0.70%)
Insider Score
/ 100
DYN Insider Score
Dyne Therapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
DYN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | 29.49 M | 24.39 M | 20.70 M | 16.67 M | 16.55 M |
| R&D Expense | 152.17 M | 100.89 M | 95.43 M | 97.22 M | 99.24 M |
| Operating Expenses | 181.66 M | 125.28 M | 116.13 M | 113.89 M | 115.79 M |
| Operating Income | -181.66 M | -125.28 M | -116.13 M | -113.89 M | -115.79 M |
| Pretax Income | -178.56 M | -120.85 M | -111.95 M | -108.04 M | -110.86 M |
| Tax Provision | — | — | — | — | — |
| Net Income | -178.56 M | -120.85 M | -111.95 M | -108.04 M | -110.86 M |
| EPS (Basic) | -1.08 | -0.73 | -0.76 | -0.76 | -0.97 |
| EPS (Diluted) | -1.08 | -0.73 | -0.76 | -0.76 | -0.97 |
| Shares Outstanding | 165.45 M | 165.04 M | 147.62 M | 141.81 M | 113.87 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.